Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Wagner

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|December 24, 2014
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitorWarren Kati, Gennadiy Koev, Michelle Irvin, et al.
Journal of Structural Biology|April 26, 2012
The crystal structure of the CRISPR-associated protein Csn2 from Streptococcus agalactiaePhilipp Ellinger, Zihni Arslan, Reinhild Wurm, et al.
Nucleic Acids Research|April 30, 2013
Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn2Zihni Arslan, Reinhild Wurm, Oleksandr Brener, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymeraseYaya Liu, Ben Hock Lim, Wen W Jiang, et al.
Antiviral Research|June 15, 2007
Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitroLiangjun Lu, Tatyana Dekhtyar, Sherie Masse, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor PibrentasvirTeresa I Ng, Preethi Krishnan, Tami Pilot-Matias, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitorsTodd D Bosse, Daniel P Larson, Rolf Wagner, et al.
Journal of Medicinal Chemistry|August 4, 2006
Novel antibacterial class: a series of tetracyclic derivativesMira M Hinman, Teresa A Rosenberg, Darlene Balli, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2020
Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitorsJohn T Randolph, Tongmei Li, A Chris Krueger, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2013
High potency improvements to weak aryl uracil HCV polymerase inhibitor leadsPamela Donner, John T Randolph, Peggy Huang, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|December 24, 2014
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitorWarren Kati, Gennadiy Koev, Michelle Irvin, et al.
Journal of Structural Biology|April 26, 2012
The crystal structure of the CRISPR-associated protein Csn2 from Streptococcus agalactiaePhilipp Ellinger, Zihni Arslan, Reinhild Wurm, et al.
Nucleic Acids Research|April 30, 2013
Double-strand DNA end-binding and sliding of the toroidal CRISPR-associated protein Csn2Zihni Arslan, Reinhild Wurm, Oleksandr Brener, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymeraseYaya Liu, Ben Hock Lim, Wen W Jiang, et al.
Antiviral Research|June 15, 2007
Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitroLiangjun Lu, Tatyana Dekhtyar, Sherie Masse, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2017
<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor PibrentasvirTeresa I Ng, Preethi Krishnan, Tami Pilot-Matias, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitorsTodd D Bosse, Daniel P Larson, Rolf Wagner, et al.
Journal of Medicinal Chemistry|August 4, 2006
Novel antibacterial class: a series of tetracyclic derivativesMira M Hinman, Teresa A Rosenberg, Darlene Balli, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2020
Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitorsJohn T Randolph, Tongmei Li, A Chris Krueger, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2013
High potency improvements to weak aryl uracil HCV polymerase inhibitor leadsPamela Donner, John T Randolph, Peggy Huang, et al.
Pageof 6